Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents

References

• Baumann L, Rodriguez D, Taylor SC, Wu J. Natural considerations for skin of color. Cutis. 2006;78:2–19
   PubMed Web of Science ®Google Scholar
• Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20–31
   PubMedGoogle Scholar
• Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869--71
   PubMed Web of Science ®Google Scholar
• Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15:894–9
   PubMed Web of Science ®Google Scholar
• Engasser PG, Maibach HI. Cosmetics and dermatology: bleaching creams. J Am Acad Dermatol. 1981;5:143–7
   PubMed Web of Science ®Google Scholar
• Kligman AM. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40--8
   PubMed Web of Science ®Google Scholar
• Kooyers T, Westerhof W. Toxicology and health risks of hydroquinone in skin lightening formulations. J Eur Acad Dermatol Venereol. 2005;20:777–80
   Web of Science ®Google Scholar
• Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet. 2002;359:431–4
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, Ebers GC, Vandervoort MK, et al. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology. 1994;44:16–16
   PubMed Web of Science ®Google Scholar
• Kimbrough-Green CK. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130:727
   PubMed Web of Science ®Google Scholar
• Pronin E, Lin DY, Ross L. The bias blind spot: perceptions of bias in self versus others. Personal Soc Psychol Bull. 2002;28:369–81
   Web of Science ®Google Scholar
• Fabi SG, Goldman MP. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging. J Drugs Dermatol. 2013;12:S32–7
   PubMed Web of Science ®Google Scholar
• Castanedo-Cazares JP, Lárraga-Piñones G, Ehnis-Pérez A, et al. Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study. Clin Cosmet Investig Dermatol. 2013;6:29–36
   PubMedGoogle Scholar
• Yun IS, Yoo H-S, Kim YO, Rah DK. Improved scar appearance with combined use of silicone gel and vitamin C for Asian patients: a comparative case series. Aesthetic Plast Surg. 2013;37:1176–81
   PubMed Web of Science ®Google Scholar
• Vázquez M, Sánchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis. 1983;32:92, 95–6
   Google Scholar
• Woodhall KE, Goldman MP, Gold MH, Biron J. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. J Drugs Dermatol. 2009;8:862–7
   PubMed Web of Science ®Google Scholar
• Zhai H, Maibach HI. Skin-whitening agents. In Paye M, Barel AO, Maibach HI eds. Handbook of Cosmetic Science and Technology, 3rd ed. Chapter 57. London, UK: Informa Healthcare, 2009. p 587--96. Available from http://informahealthcare.com/doi/abs/10.3109/9781420069686.057. Accessed July 17, 2014
   Google Scholar
• Valverde P. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet. 1996;5:1663–6
   PubMed Web of Science ®Google Scholar
• Makino ETT, Mehta RCC, Banga A, et al. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation. J Drugs Dermatol. 2013;12:s16–20
   PubMedGoogle Scholar
• Hexsel D, Hexsel C, Porto MD, Siega C. Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. J Eur Acad Dermatol Venereol. 2014. [Epub ahead of print]. doi:10.1111/jdv.12484
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Dayal S. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma. J Drugs Dermatol. 2013;12:1149–53
   PubMed Web of Science ®Google Scholar
• Makino ET, Mehta RC, Garruto J, et al. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone. J Drugs Dermatol. 2013;12:s21–6
   Google Scholar
• Bruce S, Watson J. Evaluation of a prescription strength 4% hydroquinone/10% L-ascorbic acid treatment system for normal to oily skin. J Drugs Dermatol. 2011;10:1455–61
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Kenkel J, Werschler P. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A. Aesthet Surg J. 2011;31:529–39
   PubMedGoogle Scholar
• Costa A, Moisés TA, Cordero T, et al. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol. 2010;85:613–20
   PubMed Web of Science ®Google Scholar
• Draelos ZD, Yatskayer M, Bhushan P, et al. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis. 2010;86:153–8
   PubMed Web of Science ®Google Scholar
• Grimes PE, Bhawan J, Guevara IL, et al. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma. J Am Acad Dermatol. 2010;62:962–7
   PubMed Web of Science ®Google Scholar
• Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011:1–5
   Google Scholar
• Gold M, Rendon M, Dibernardo B, et al. Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin cream. J Clin Aesthet Dermatol. 2013;6:32–8
   PubMedGoogle Scholar
• Deo KS, Dash KN, Sharma YK, et al. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013;58:281–5
   PubMedGoogle Scholar
• Monteiro RC, Kishore BN, Bhat RM, et al. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58:157
   PubMedGoogle Scholar
• Grimes P, Watson J. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%. Cutis. 2013;91:47–54
   PubMed Web of Science ®Google Scholar
• Dahl A, Yatskayer M, Raab S, Oresajo C. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone. J Drugs Dermatol. 2013;12:52–8
   PubMed Web of Science ®Google Scholar
• Iraji F, Tagmirriahi N, Gavidnia K. Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma. Adv Biomed Res. 2012;1:39
   PubMedGoogle Scholar
• Farshi S. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. J Cosmet Dermatol. 2011;10:282–7
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Parr L. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin. J Drugs Dermatol. 2010;9:220–6
   PubMed Web of Science ®Google Scholar
• Godse KV. Triple combination of hydroquinone, tretinoin and mometasone furoate with glycolic acid peels in melasma. Indian J Dermatol. 2009;54:92–3
   PubMedGoogle Scholar
• Woodhall KE, Goldman MP, Gold MH, Biron J. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. J Drugs Dermatol. 2009;8:862–7
   PubMed Web of Science ®Google Scholar
• Tirado-Sánchez A, Santamaría-Román A, Ponce-Olivera RM. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma. Int J Dermatol. 2009;48:893–5
   PubMed Web of Science ®Google Scholar
• Salem A, Gamil H, Ramadan A, et al. Melasma: treatment evaluation. J Cosmet Laser Ther. 2009;11:146–50
   PubMed Web of Science ®Google Scholar
• Sadick Research Group; Sadick Research Group. Evaluation of an herbal-based depigmenting system. In ClinicalTrials.gov [Internet]. Betheseda (MD): National Library of Medicine (US), 2000. Available from http://clinicaltrials.gov/ct2/s. Accessed July 29, 2014
   Google Scholar
• Brazilan Center for Studies in Dermatology. A fixed triple combination cream for solar lentigines associated to cryotherapy. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from https://clinicaltrials.gov/ct2/show/NCT01778179?term=A+fixed+triple+combination+cream+for+solar+lentigines+associated+to+cryotherapy&rank=1. Accessed July 29, 2014
   Google Scholar
• Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice. Treatment of melasma with stabilized kligman preparation associated or not with pulsed dye laser. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from https://clinicaltrials.gov/ct2/show/NCT00863278?term=treatment+of+melasma+with+stabilized+kligman+preparation+associated+or+not+with+pulsed+dye+laser&rank=1. Accessed December 30, 2014
   Google Scholar
• Castanedo-Cazares, Juan Pablo; Universidad Autonoma de San Luis Potosi. Clinical trial of hydroquinone versus miconazol in melasma. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from https://clinicaltrials.gov/ct2/show/NCT00927771?term=azelaic+acid+versus+hydroquinone+in+melasma&rank=1. Accessed July 29, 2014
   Google Scholar
• Callender Center for Clinical Research; Callender Center for Clinical Research. Azelaic acid versus hydroquinone in melasma. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: ht. Accessed July 29, 2014
   Google Scholar
• Mesoestetic Pharma Group S.L.; Mesoestetic Pharma Group S.L. Efficacy and safety of a 4% hydroquinone cream (melanoderm 4%) for the treatment of melasma: a randomized controlled split-face study. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from https://clinicaltrials.gov/ct2/show/NCT02095990?term=efficacy+and+safety+of+a+4%25+hydroquinone+cream+for+the+treatment+of+melasma&rank=1. Accessed December 30, 2014
   Google Scholar
• Pandya A. University of Texas Southwestern Medical Center. Salicylic acid peels combined with 4% hydroquinone in the treatment of moderate to severe melasma in hispanic women. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine. Available from https://clinicaltrials.gov/ct2/show/results/NCT00616239?term=Salicylic+acid+peels+combined+with+4%25+hydroquinone+in+the+treatment+of+moderate+to+severe+melasma+in+hispanic+women&rank=1&sect=X70156#outcome1. Accessed December 30, 2014
   Google Scholar
• Sobhi RM, Sobhi AM. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma. J Cosmet Dermatol. 2012;11:65–71
   PubMed Web of Science ®Google Scholar
• Taylor MB, Yanaki JS, Draper DO, et al. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen. J Drugs Dermatol. 2013;12:45–50
   PubMed Web of Science ®Google Scholar
• Ohshima H, Mizukoshi K, Oyobikawa M, et al. Effects of vitamin C on dark circles of the lower eyelids: quantitative evaluation using image analysis and echogram. Skin Res Technol. 2009;15:214–17
   PubMed Web of Science ®Google Scholar
• Handog EB, Galang DAVF, de Leon-Godinez MA, Chan GP. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women. Int J Dermatol. 2009;48:896–901
   PubMed Web of Science ®Google Scholar
• National University Hospital, Singapore. The efficacy and safety of a single 70% glycolic acid peel with vitamin c for the treatment of acne scars. In ClinicalTrials.gov [Internet]. Bethesda (MD): Nationa Library of Medicine (US). 2000. Accessed July 29, 2014
   Google Scholar
• Englewood Hospital and Medical Center. Microneedling plus the universal peel for acne scarring. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: NCT02174393 NLM Identifier: NCT. Accessed July 29, 2014
   Google Scholar
• Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586–90
   PubMed Web of Science ®Google Scholar
• Derm Research, PLLC. Efficacy and safety study of finacea to treat acne vulgaris and post-inflammatory hyperpigmentation. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from https://clinicaltrials.gov/ct2/show/NCT01038869?term=efficacy+and+safety+study+of+finacea+to+treat+acne+vulgaris+and+post-inflammatory+hyperpigmentation&rank=1. Accessed July 29, 2014
   Google Scholar
• Medical University of Vienna. Azelaic acid iontophoresis versus topical azelaic acid cream in the treatment of melasma. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from https://clinicaltrials.gov/ct2/show/NCT00848458?term=azelaic+acid+iontophoresis+versus+topical+azelaic+acid+cream+in+the+treatment+of+melasma&rank=1. Accessed July 29, 2014
   Google Scholar
• Herndon JH, Makino ET, Stephens TJ, Mehta RC. Hydroquinone-free skin brightener system for the treatment of moderate-to-severe facial hyperpigmentation. J Clin Aesthet Dermatol. 2014;7:27–31
   PubMedGoogle Scholar
• Ho ET, Trookman NS, Sperber BR, et al. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%. J Drugs Dermatol. 2012;11:64–9
   PubMed Web of Science ®Google Scholar
• Shi T-W, Ren X-K, Yu H-X, Tang Y-B. Roles of adapalene in the treatment of pityriasis versicolor. Dermatology. 2012;224:184–8
   PubMed Web of Science ®Google Scholar
• Kircik LH. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study. J Drugs Dermatol. 2012;11:83–90
   PubMed Web of Science ®Google Scholar
• Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76:447
   PubMed Web of Science ®Google Scholar
• Ghersetich I, Troiano M, Brazzini B, et al. Melasma: treatment with 10% tretinoin peeling mask. J Cosmet Dermatol. 2010;9:117–21
   PubMedGoogle Scholar
• Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color. J Clin Aesthet Dermatol. 2012;5:25–32
   PubMedGoogle Scholar
• Callender Center for Clinical Research. Efficacy & safety of clindamycin and tretinoin in acne. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: http://clinicaltrials.gov/show/. Accessed July 29, 2014
   Google Scholar
• Massachusetts General Hospital. Study to evaluate the effect of a nu skin product and device for brown spots. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: http://clinicaltr. Accessed July 29, 2014
   Google Scholar
• Kimball AB, Kaczvinsky JR, Li J, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162:435–41
   PubMed Web of Science ®Google Scholar
• Lee DH, Oh IY, Koo KT, et al. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial. Skin Res Technol. 2014;20:208–12
   PubMed Web of Science ®Google Scholar
• Jerajani HR, Mizoguchi H, Li J, et al. The effects of a daily facial lotion containing vitamins B3 and E and provitamin B5 on the facial skin of Indian women: a randomized, double-blind trial. Indian J Dermatol Venereol Leprol. 2010;76:20–6
   PubMed Web of Science ®Google Scholar
• Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-l-phenylalanine and its combination with niacinamide. J Cosmet Dermatol. 2009;8:260–6
   PubMedGoogle Scholar
• Universidad Autonoma de San Luis Potosi. Clinical trial of 4% niacinamide versus 0.05% desonide for the treatment of axillar hyperpigmentation. In ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from https://clinicaltrials.gov/ct2/show/NCT01542138?term=clinical+trial+of+4%25+niacinamide+versus+0.05%25+desonide+for+the+treatment+of+axillar+hyperpigmentation&rank=1. Accessed July 29, 2014
   Google Scholar
• University of Utah; University of Utah. Combination therapy with imiquimod cream 5% and tazarotene cream 0.1% for the treatment of lentigo maligna. In ClinicalTrails.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000–2013. Available from https://clinicaltrials.gov/ct2/show/NCT00707174?term=Combination+therapy+with+imiquimod+cream+5%25+and+tazarotene+cream+0.1%25+for+the+treatment+of+lentigo+maligna&rank=1
   Google Scholar